Novartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. | ...

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...

Prostate cancer is one of the most common cancers in men in the United States. While one in nine men will be diagnosed with ...

Cubs legend and Baseball Hall of Fame member Ryne Sandberg provided an update on health Wednesday morning in a statement ...

Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on ...

Brachytherapy Awareness Day highlights the value of this precise form of internal radiotherapy in treating cancer. Organised by several oncology organisations, the initiative showcases evidence that ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

Although an elevated PSA measurement can indicate prostate cancer, there can be other reasons for elevated levels.

Kenya’s fight against cancer has entered a new phase, driven by technological breakthroughs that promise to transform diagnosis, treatment, and survival rates.

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic prostate cancer.

ArteraAI Prostate analyzes digital pathology images of a prostate cancer biopsy slide to help clinicians predict long-term outcomes.